Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)
CUSIP: 51654W101
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 11,280,432
- Total 13F shares
- 1,417,902
- Share change
- -36,161
- Total reported value
- $8,060,000
- Price per share
- $5.70
- Number of holders
- 25
- Value change
- -$230,429
- Number of buys
- 11
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 51654W101?
CUSIP 51654W101 identifies LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 51654W101:
Top shareholders of LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
3.4%
|
384,228
|
$2,747,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
367,319
|
$2,626,000 | — | 31 Mar 2022 | |
| NewEdge Advisors, LLC |
13F
|
Company |
1.5%
|
169,771
|
$1,214,000 | — | 31 Mar 2022 | |
| Carlson Capital, L.P. |
13F
|
Company |
1.5%
|
167,300
|
$1,196,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
57,043
|
$407,000 | — | 31 Mar 2022 | |
| Redmond Asset Management, LLC |
13F
|
Company |
0.44%
|
49,793
|
$356,000 | — | 31 Mar 2022 | |
| WOLFF WIESE MAGANA LLC |
13F
|
Company |
0.32%
|
36,155
|
$259,000 | — | 31 Mar 2022 | |
| CM Management, LLC |
13F
|
Company |
0.3%
|
33,765
|
$241,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
27,752
|
$198,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
26,765
|
$191,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.2%
|
23,074
|
$164,000 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.18%
|
20,322
|
$145,000 | — | 31 Mar 2022 | |
| Sigma Planning Corp |
13F
|
Company |
0.16%
|
17,600
|
$126,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
13,936
|
$100,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
12,901
|
$92,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
12,629
|
$90,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
10,700
|
$77,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
8,018
|
$57,000 | — | 31 Mar 2022 | |
| Spire Wealth Management |
13F
|
Company |
0.04%
|
4,050
|
$29,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
3,513
|
$25,000 | — | 31 Mar 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
3,075
|
$22,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,290
|
$9,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
773
|
$6,000 | — | 31 Mar 2022 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
809
|
$5,000 | — | 31 Mar 2022 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
300
|
$2,000 | — | 31 Mar 2022 | |
| Franklyn G. Prendergast |
3/4/5
|
Director |
—
class O/S missing
|
3,200
|
— | — | 04 Nov 2021 |
Institutional Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q2 2022
As of 30 Jun 2022,
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,417,902 shares.
The largest 10 holders included
VANGUARD GROUP INC, SANDERS MORRIS HARRIS LLC, CARLSON CAPITAL L P, NewEdge Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, Redmond Asset Management, LLC, CM Management, LLC, WOLFF WIESE MAGANA LLC, STATE STREET CORP, and Bank of New York Mellon Corp.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
25
Q2 2022 holders
25
Holder diff
0
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.